Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Harvey

Showing results (441-450 of 1,503) with videos related to

Pageof 151
Sort By:
Chemico-Biological Interactions|January 1, 1987
Electron donor properties of the antitumour drug amsacrine as studied by fluorescence quenching of DNA-bound ethidiumL M Davis, J D Harvey, B C Baguley
Physical Review Letters|April 12, 2003
Exact self-similar solutions of the generalized nonlinear Schrödinger equation with distributed coefficientsV I Kruglov, A C Peacock, J D Harvey
Social Science & Medicine (1982)|February 9, 2021
Minority stress, psychosocial health, and survival among gay and bisexual men before, during, and after incarcerationTyler D Harvey, Danya E Keene, John E Pachankis
NPJ Schizophrenia|February 27, 2021
Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment developmentGregory P Strauss, Lisa A Bartolomeo, Philip D Harvey
The Journal of Organic Chemistry|February 23, 2019
Characterization and Minimization of Glaser Competitive Homocoupling in Sonogashira Porphyrin-Based PolycondensationLoïc Tanguy, Ophélie Hetru, Adam Langlois, et al.
Psychiatry Research|January 7, 2022
Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammationCaleb Labonté, Naista Zhand, Angela Park, et al.
Expert Opinion on Emerging Drugs|May 26, 2020
Emerging 5-HT receptor antagonists for the treatment of SchizophreniaMackenzie T Jones, Martin T Strassnig, Philip D Harvey
Photochemistry and Photobiology|September 10, 2005
Photophysical properties of a rhodium tetraphenylporphyrin-tin corrole dyad. The first example of a through metal-metal bond energy transferJason Poulin, Christine Stern, Roger Guilard, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 23, 2011
Schizophrenia in later lifePhilip D Harvey, Sara J Czaja, David A Loewenstein
Journal of Separation Science|August 4, 2011
Evaluation of copper-1,3,5-benzenetricarboxylate metal-organic framework (Cu-MOF) as a selective sorbent for Lewis-base analytesScott D Harvey, Alison D Eckberg, Praveen K Thallapally
Pageof 151

Showing results (441-450 of 1,503) with videos related to

Sort By:
Pageof 151
Chemico-Biological Interactions|January 1, 1987
Electron donor properties of the antitumour drug amsacrine as studied by fluorescence quenching of DNA-bound ethidiumL M Davis, J D Harvey, B C Baguley
Physical Review Letters|April 12, 2003
Exact self-similar solutions of the generalized nonlinear Schrödinger equation with distributed coefficientsV I Kruglov, A C Peacock, J D Harvey
Social Science & Medicine (1982)|February 9, 2021
Minority stress, psychosocial health, and survival among gay and bisexual men before, during, and after incarcerationTyler D Harvey, Danya E Keene, John E Pachankis
NPJ Schizophrenia|February 27, 2021
Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment developmentGregory P Strauss, Lisa A Bartolomeo, Philip D Harvey
The Journal of Organic Chemistry|February 23, 2019
Characterization and Minimization of Glaser Competitive Homocoupling in Sonogashira Porphyrin-Based PolycondensationLoïc Tanguy, Ophélie Hetru, Adam Langlois, et al.
Psychiatry Research|January 7, 2022
Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammationCaleb Labonté, Naista Zhand, Angela Park, et al.
Expert Opinion on Emerging Drugs|May 26, 2020
Emerging 5-HT receptor antagonists for the treatment of SchizophreniaMackenzie T Jones, Martin T Strassnig, Philip D Harvey
Photochemistry and Photobiology|September 10, 2005
Photophysical properties of a rhodium tetraphenylporphyrin-tin corrole dyad. The first example of a through metal-metal bond energy transferJason Poulin, Christine Stern, Roger Guilard, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 23, 2011
Schizophrenia in later lifePhilip D Harvey, Sara J Czaja, David A Loewenstein
Journal of Separation Science|August 4, 2011
Evaluation of copper-1,3,5-benzenetricarboxylate metal-organic framework (Cu-MOF) as a selective sorbent for Lewis-base analytesScott D Harvey, Alison D Eckberg, Praveen K Thallapally
Pageof 151